Guangzhou Weimi Bio-Tech Co., Ltd.
PrivateLast Round
Series B
Oct 1, 2021
Total Funding Raised
$15.5M
Company Overview
Guangzhou Weimi Bio-Tech Co., Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series B round in October 2021.
Guangzhou Weimi Bio-Tech Co., Ltd. is a biotechnology company that develops, manufactures, and distributes in vitro diagnostic (IVD) products and point-of-care testing solutions for medical practitioners.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Weimi Bio-Tech Co., Ltd. Comparables
Compare Guangzhou Weimi Bio-Tech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zybio Inc. | 83% | |
| Wellgrow Technology | 82% | |
| Getein Biotech Inc | 79% |
For institutional investors. Book with your work email.
Guangzhou Weimi Bio-Tech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 1, 2021 | ||||
| Series A | Nov 1, 2018 |
For institutional investors. Book with your work email.
Guangzhou Weimi Bio-Tech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CCIC Capital | Series B |
| Qianshan Capital Management Co., Ltd. | Series A |
| Chuangyu Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2021
$16M round led by CCIC Capital
- Nov 1, 2018
Raised Series A round with Qianshan Capital Management Co., Ltd. as an investor.
For institutional investors. Book with your work email.
Guangzhou Weimi Bio-Tech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guangzhou Weimi Bio-Tech Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Weimi Bio-Tech Co., Ltd. a public or private company?
Guangzhou Weimi Bio-Tech Co., Ltd. is a private company.
What is the current stock price of Guangzhou Weimi Bio-Tech Co., Ltd.?
Guangzhou Weimi Bio-Tech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Guangzhou Weimi Bio-Tech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guangzhou Weimi Bio-Tech Co., Ltd. worth (valuation)?
Valuation information for Guangzhou Weimi Bio-Tech Co., Ltd. is not publicly available.
Can I buy Guangzhou Weimi Bio-Tech Co., Ltd. stock?
Guangzhou Weimi Bio-Tech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guangzhou Weimi Bio-Tech Co., Ltd.'s last funding round?
Guangzhou Weimi Bio-Tech Co., Ltd.'s most recent funding round was Series B on October 1, 2021.
Who are the main investors in Guangzhou Weimi Bio-Tech Co., Ltd.?
Key investors in Guangzhou Weimi Bio-Tech Co., Ltd. include CCIC Capital.
Will Guangzhou Weimi Bio-Tech Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Weimi Bio-Tech Co., Ltd..
How can I track Guangzhou Weimi Bio-Tech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Guangzhou Weimi Bio-Tech Co., Ltd.'s shares on secondary markets.